BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31846965)

  • 1. Hippocampal Volume Loss, Brain Amyloid Accumulation, and APOE Status in Cognitively Intact Elderly Subjects.
    Haller S; Montandon ML; Rodriguez C; Garibotto V; Herrmann FR; Giannakopoulos P
    Neurodegener Dis; 2019; 19(3-4):139-147. PubMed ID: 31846965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.
    Jack CR; Wiste HJ; Weigand SD; Knopman DS; Vemuri P; Mielke MM; Lowe V; Senjem ML; Gunter JL; Machulda MM; Gregg BE; Pankratz VS; Rocca WA; Petersen RC
    JAMA Neurol; 2015 May; 72(5):511-9. PubMed ID: 25775353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly.
    Snellman A; Ekblad LL; Tuisku J; Koivumäki M; Ashton NJ; Lantero-Rodriguez J; Karikari TK; Helin S; Bucci M; Löyttyniemi E; Parkkola R; Karrasch M; Schöll M; Zetterberg H; Blennow K; Rinne JO
    Alzheimers Res Ther; 2023 Apr; 15(1):71. PubMed ID: 37016464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.
    Lim YY; Kalinowski P; Pietrzak RH; Laws SM; Burnham SC; Ames D; Villemagne VL; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe CC; Masters CL; Maruff PT
    JAMA Neurol; 2018 Apr; 75(4):488-494. PubMed ID: 29356823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex,
    Therriault J; Pascoal TA; Benedet AL; Tissot C; Savard M; Chamoun M; Lussier F; Kang MS; Berzgin G; Wang T; Fernandes-Arias J; Massarweh G; Soucy JP; Vitali P; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
    Neurology; 2021 Feb; 96(7):e975-e985. PubMed ID: 33443136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma NfL is associated with the APOE ε4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults.
    Malek-Ahmadi M; Su Y; Ghisays V; Luo J; Devadas V; Chen Y; Lee W; Protas H; Chen K; Zetterberg H; Blennow K; Caselli RJ; Reiman EM
    Alzheimers Res Ther; 2023 Apr; 15(1):74. PubMed ID: 37038190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
    Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
    Voevodskaya O; Sundgren PC; Strandberg O; Zetterberg H; Minthon L; Blennow K; Wahlund LO; Westman E; Hansson O;
    Neurology; 2016 May; 86(19):1754-61. PubMed ID: 27164711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.
    Drzezga A; Grimmer T; Henriksen G; Mühlau M; Perneczky R; Miederer I; Praus C; Sorg C; Wohlschläger A; Riemenschneider M; Wester HJ; Foerstl H; Schwaiger M; Kurz A
    Neurology; 2009 Apr; 72(17):1487-94. PubMed ID: 19339712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.
    Gu Y; Razlighi QR; Zahodne LB; Janicki SC; Ichise M; Manly JJ; Devanand DP; Brickman AM; Schupf N; Mayeux R; Stern Y
    PLoS One; 2015; 10(7):e0123743. PubMed ID: 26221954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderating effect of
    Hwang JY; Byun MS; Choe YM; Lee JH; Yi D; Choi JW; Hwang SH; Lee YJ; Lee DY;
    Neurology; 2018 Mar; 90(13):e1167-e1173. PubMed ID: 29490913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ApoE-epsilon4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons.
    Crivello F; Lemaître H; Dufouil C; Grassiot B; Delcroix N; Tzourio-Mazoyer N; Tzourio C; Mazoyer B
    Neuroimage; 2010 Nov; 53(3):1064-9. PubMed ID: 20060049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid and APOE Status of Screened Subjects in the Elenbecestat MissionAD Phase 3 Program.
    Roberts C; Kaplow J; Giroux M; Krause S; Kanekiyo M
    J Prev Alzheimers Dis; 2021; 8(2):218-223. PubMed ID: 33569570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical ¹¹C-PIB uptake is associated with age, APOE genotype, and gender in "healthy aging".
    Scheinin NM; Wikman K; Jula A; Perola M; Vahlberg T; Rokka J; Någren K; Viitanen M; Rinne JO
    J Alzheimers Dis; 2014; 41(1):193-202. PubMed ID: 24603945
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Nedelska Z; Przybelski SA; Lesnick TG; Schwarz CG; Lowe VJ; Machulda MM; Kremers WK; Mielke MM; Roberts RO; Boeve BF; Knopman DS; Petersen RC; Jack CR; Kantarci K
    Neurology; 2017 Sep; 89(13):1391-1399. PubMed ID: 28842444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.